Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Impact of the type of centre on management of AF patients: surprising evidence for differences in antithrombotic therapy decisions.

Kirchhof P, Nabauer M, Gerth A, Limbourg T, Lewalter T, Goette A, Wegscheider K, Treszl A, Meinertz T, Oeff M, Ravens U, Breithardt G, Steinbeck G; AFNET registry investigators.

Thromb Haemost. 2011 Jun;105(6):1010-23. doi: 10.1160/TH11-02-0070. Epub 2011 May 5.

PMID:
21544322
2.

Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry.

Meinertz T, Kirch W, Rosin L, Pittrow D, Willich SN, Kirchhof P; ATRIUM investigators.

Clin Res Cardiol. 2011 Oct;100(10):897-905. doi: 10.1007/s00392-011-0320-5. Epub 2011 May 1.

3.

A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry.

Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Oliveira MM, Mairesse G, Crijns HJ, Simantirakis E, Atar D, Kirchhof P, Vardas P, Tavazzi L, Maggioni AP.

Europace. 2014 Mar;16(3):308-19. doi: 10.1093/europace/eut373. Epub 2013 Dec 17. Erratum in: Europace. 2014 Jun;16(6):941.

4.

Guideline adherence of antithrombotic treatment initiated by general practitioners in patients with nonvalvular atrial fibrillation: a Danish survey.

Brandes A, Overgaard M, Plauborg L, Dehlendorff C, Lyck F, Peulicke J, Poulsen SV, Husted S.

Clin Cardiol. 2013 Jul;36(7):427-32. doi: 10.1002/clc.22133. Epub 2013 May 13.

5.

Provider specialty and atrial fibrillation treatment strategies in United States community practice: findings from the ORBIT-AF registry.

Fosbol EL, Holmes DN, Piccini JP, Thomas L, Reiffel JA, Mills RM, Kowey P, Mahaffey K, Gersh BJ, Peterson ED; ORBIT-AF Investigators and Patients.

J Am Heart Assoc. 2013 Jul 18;2(4):e000110. doi: 10.1161/JAHA.113.000110.

6.

Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.

Anderson DR, Gardner MJ, Putnam W, Jassal D, Brownell B, Flowerdew G, Nagpal S, Thompson K, Cox JL.

Can J Cardiol. 2005 Mar;21(3):257-66.

PMID:
15776115
7.

Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF).

Kirchhof P, Ammentorp B, Darius H, De Caterina R, Le Heuzey JY, Schilling RJ, Schmitt J, Zamorano JL.

Europace. 2014 Jan;16(1):6-14. doi: 10.1093/europace/eut263. Epub 2013 Oct 1.

8.

An international longitudinal registry of patients with atrial fibrillation at risk of stroke (GARFIELD): the UK protocol.

Apenteng PN, Murray ET, Holder R, Hobbs FD, Fitzmaurice DA; UK GARFIELD Investigators and GARFIELD Steering Committee.

BMC Cardiovasc Disord. 2013 Apr 23;13:31. doi: 10.1186/1471-2261-13-31.

9.
10.

The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management.

Nabauer M, Gerth A, Limbourg T, Schneider S, Oeff M, Kirchhof P, Goette A, Lewalter T, Ravens U, Meinertz T, Breithardt G, Steinbeck G.

Europace. 2009 Apr;11(4):423-34. doi: 10.1093/europace/eun369. Epub 2009 Jan 18.

11.

Baseline characteristics of patients from Poland enrolled in the global registry of patients with recently diagnosed atrial fibrillation (RecordAF).

Opolski G, Kosior DA, Kurzelewski M, Skrzyńska M, Zagórski A, Janion M, Muzolf M, Wlazłowski R, Pankiewicz B, Łoboz-Grudzień K, Breithardt G; Polish RecordAF.

Kardiol Pol. 2010 May;68(5):546-54.

12.

Current presentation and management of 7148 patients with atrial fibrillation in cardiology and internal medicine hospital centers: the ATA AF study.

Di Pasquale G, Mathieu G, Maggioni AP, Fabbri G, Lucci D, Vescovo G, Pirelli S, Chiarella F, Scherillo M, Gulizia MM, Gussoni G, Colombo F, Panuccio D, Nozzoli C, Berisso MZ; ATA-AF Investigators.

Int J Cardiol. 2013 Sep 10;167(6):2895-903. doi: 10.1016/j.ijcard.2012.07.019. Epub 2012 Aug 11.

PMID:
22884698
13.

Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany - results from the German AFNET registry.

Haeusler KG, Gerth A, Limbourg T, Tebbe U, Oeff M, Wegscheider K, Treszl A, Ravens U, Meinertz T, Kirchhof P, Breithardt G, Steinbeck G, Nabauer M; AFNET registry investigators.

BMC Neurol. 2015 Aug 5;15:129. doi: 10.1186/s12883-015-0371-8.

14.

Antiarrhythmic strategies in patients with atrial fibrillation managed by cardiologists and internists: Antithrombotic Agents in Atrial Fibrillation (ATA-AF) survey.

Berisso MZ, Fabbri G, Gonzini L, Caruso D, Fontanella A, Pellegrini F, Silvestri N, Vincenti A, Mathieu G, Di Pasquale G; ATA-AF Investigators.

J Cardiovasc Med (Hagerstown). 2014 Aug;15(8):626-35. doi: 10.2459/JCM.0000000000000110.

PMID:
24978662
15.

The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.

Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY.

Thromb Haemost. 2012 Jun;107(6):1172-9. doi: 10.1160/TH12-03-0175. Epub 2012 Apr 3.

PMID:
22473219
16.

Use of antithrombotics in atrial fibrillation in Africa, Europe, Asia and South America: insights from the International RealiseAF Survey.

Gamra H, Murin J, Chiang CE, Naditch-Brûlé L, Brette S, Steg PG; RealiseAF investigators.

Arch Cardiovasc Dis. 2014 Feb;107(2):77-87. doi: 10.1016/j.acvd.2014.01.001. Epub 2014 Feb 18.

17.

Incidence, prevalence, and antithrombotic management of atrial fibrillation in elderly Germans.

Ohlmeier C, Mikolajczyk R, Haverkamp W, Garbe E.

Europace. 2013 Oct;15(10):1436-44. doi: 10.1093/europace/eut048. Epub 2013 Mar 13.

18.

Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.

Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, Rolf S, Richter S, Piorkowski C, Gaspar T, Lip GY, Bollmann A.

Circ Arrhythm Electrophysiol. 2013 Oct;6(5):868-74. doi: 10.1161/CIRCEP.113.000869. Epub 2013 Sep 18.

19.

Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.

Taillandier S, Olesen JB, Clémenty N, Lagrenade I, Babuty D, Lip GY, Fauchier L.

J Cardiovasc Electrophysiol. 2012 Jul;23(7):708-13. doi: 10.1111/j.1540-8167.2011.02257.x. Epub 2012 Jan 23.

PMID:
22268375
20.

Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients.

Wilke T, Groth A, Mueller S, Pfannkuche M, Verheyen F, Linder R, Maywald U, Kohlmann T, Feng YS, Breithardt G, Bauersachs R.

Thromb Haemost. 2012 Jun;107(6):1053-65. doi: 10.1160/TH11-11-0768. Epub 2012 Mar 8.

PMID:
22398417
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk